Ayse T. Tuglular

Ihlas Marmara Evleri - I. Kisim, 34899, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology.

Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology.

Journal: Journal of clinical medicine

Published: June 24, 2026

Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study.

Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study.

Journal: Frontiers in medicine

Published: March 12, 2026

Comparative Evaluation of Single-Dose and Split-Dose Melphalan Conditioning Concerning Toxicity Profiles and Engraftment Kinetics: A Propensity Score-Matched Analysis.

Comparative Evaluation of Single-Dose and Split-Dose Melphalan Conditioning Concerning Toxicity Profiles and Engraftment Kinetics: A Propensity Score-Matched Analysis.

Journal: Transplantation and cellular therapy

Published: March 09, 2026

HIV-associated lymphoproliferative disorders: Single-center experience.

HIV-associated lymphoproliferative disorders: Single-center experience.

Journal: Medicine

Published: November 05, 2025

Determinants of Eligibility and Timing of Autologous Transplantation in Multiple Myeloma: The Role of R-MCI and Diagnostic Plasma Cell Burden.

Determinants of Eligibility and Timing of Autologous Transplantation in Multiple Myeloma: The Role of R-MCI and Diagnostic Plasma Cell Burden.

Journal: Diagnostics (Basel, Switzerland)

Published: November 03, 2025

The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia.

The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia.

Journal: Journal of clinical medicine

Published: September 17, 2025

RNA sequencing detects more challenging cases of somatic hypermutation in the IgHV gene in patients with chronic lymphocytic leukemia.

RNA sequencing detects more challenging cases of somatic hypermutation in the IgHV gene in patients with chronic lymphocytic leukemia.

Journal: Turkish journal of medical sciences

Published: July 04, 2025

Acute lymphoblastic leukemia following lenalidomide therapy in multiple myeloma patients: Two case reports and review of the literature.

Acute lymphoblastic leukemia following lenalidomide therapy in multiple myeloma patients: Two case reports and review of the literature.

Journal: Current problems in cancer

Published: January 30, 2025

Bortezomib-Based Salvage Followed by Autologous Transplantation in a Patient with HIV-Negative Plasmablastic Lymphoma.

Bortezomib-Based Salvage Followed by Autologous Transplantation in a Patient with HIV-Negative Plasmablastic Lymphoma.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: November 07, 2024

Peripheral T-Cell Lymphoma Coexisting with Autoimmune Hemolytic Anemia: Analysis of Clinical Features.

Peripheral T-Cell Lymphoma Coexisting with Autoimmune Hemolytic Anemia: Analysis of Clinical Features.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: March 15, 2024

The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.

The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.

Journal: International journal of hematologic oncology

Published: May 31, 2021

Molecular screening and the clinical impacts of BCR-ABL KD mutations in patients with imatinib-resistant chronic myeloid leukemia.

Molecular screening and the clinical impacts of BCR-ABL KD mutations in patients with imatinib-resistant chronic myeloid leukemia.

Journal: Oncology letters

Published: June 16, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026